HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)
IceCure Medical (NASDAQ:ICCM – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $3.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 305.41% from the stock’s […]
More Stories
5N Plus Inc. (OTCMKTS:FPLSF) Sees Significant Decline in Short Interest
5N Plus Inc. (OTCMKTS:FPLSF – Get Free Report) saw a significant decrease in short interest in the month of October....
Lloyds Banking Group plc (NYSE:LYG) Short Interest Update
Lloyds Banking Group plc (NYSE:LYG – Get Free Report) saw a significant increase in short interest during the month of...
Short Interest in Jaguar Mining Inc. (OTCMKTS:JAGGF) Increases By 15.3%
Jaguar Mining Inc. (OTCMKTS:JAGGF – Get Free Report) was the recipient of a significant growth in short interest in the...
Short Interest in Fossil Group, Inc. 7% Senior Notes due 2026 (NASDAQ:FOSLL) Grows By 16.0%
Fossil Group, Inc. 7% Senior Notes due 2026 (NASDAQ:FOSLL – Get Free Report) was the target of a significant increase...
Humana Inc. (NYSE:HUM) Sees Large Growth in Short Interest
Humana Inc. (NYSE:HUM – Get Free Report) saw a significant increase in short interest in the month of October. As...
Stocks Sell Off at End of Week on Profit-Taking Ahead of Nvidia Earnings Report
By Panos Mourdoukoutas U.S. stocks ended the week with a sell-off due to profit-taking, rising bond yields, and disappointing earnings...